Bicuspid Aortopathy Toward Individualized Risk Assessment With Imaging Biomarkers COMMENT

被引：2
|
作者：
Michelena, Hector I. [1 ]
机构：
[1] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA
来源：
JACC-CARDIOVASCULAR IMAGING | 2022年 / 15卷 / 01期
关键词：
aortic aneurysm; bicuspid aortic valve; dilation mapping; growth rate; wall shear stress; AORTIC-VALVE;
D O I：
10.1016/j.jcmg.2021.10.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：57 / 59
页数：3
相关论文
共 50 条
  • [31] Toward Imaging Biomarkers for Glycosaminoglycans
    Gray, Martha L.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2009, 91A : 44 - 49
  • [32] Toward imaging biomarkers for osteoarthritis
    Gray, ML
    Eckstein, F
    Peterfy, C
    Dahlberg, L
    Kim, YJ
    Sorensen, AG
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2004, (427) : S175 - S181
  • [33] Harnessing imaging biomarkers to refine individualized cardiovascular disease risk: a case-based discussion
    Almeida, Shone
    Shaikh, Kashif
    Memon, Saira
    Singh, Vasvi
    Thomas, Drew
    CORONARY ARTERY DISEASE, 2022, 33 (07) : 574 - 579
  • [34] Toward individualized quality-of-life assessment
    Pouchot, J
    JOINT BONE SPINE, 2000, 67 (02): : 83 - 85
  • [35] Integrating Biomarkers and Imaging for Cardiovascular Disease Risk Assessment in Diabetes
    Tehrani, David M.
    Wong, Nathan D.
    CURRENT CARDIOLOGY REPORTS, 2016, 18 (11)
  • [36] Integrating Biomarkers and Imaging for Cardiovascular Disease Risk Assessment in Diabetes
    David M. Tehrani
    Nathan D. Wong
    Current Cardiology Reports, 2016, 18
  • [37] Plaque characterization and individualized risk assessment
    Brendel, J. M.
    Nikolaou, K.
    Foldyna, B.
    RADIOLOGIE, 2024, 64 (12): : 946 - 955
  • [38] Individualized assessment of prostate cancer risk
    Jan Adolfsson
    Nature Clinical Practice Urology, 2006, 3 : 522 - 523
  • [39] Individualized toxicity is the future of risk assessment
    Boobis, Alan R.
    Pettit, Syril D.
    TOXICOLOGY LETTERS, 2021, 350 : S11 - S11
  • [40] The future of genetic and genomic medicine in health risk assessment and disease: a path toward individualized medicine
    Zaiou, M
    PHARMACOGENOMICS, 2005, 6 (01) : 7 - 12
12345